182 related articles for article (PubMed ID: 18364752)
1. Diabetes eye screening in the Wellington region of New Zealand: characteristics of the enrolled population (2002-2005).
Frederikson LG; Jacobs RJ
N Z Med J; 2008 Mar; 121(1270):21-34. PubMed ID: 18364752
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetic retinopathy and maculopathy in Northland, New Zealand: 2011-2012.
Papali'i-Curtin AT; Dalziel DM
N Z Med J; 2013 Sep; 126(1383):20-8. PubMed ID: 24157988
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan.
Jamal-u-Din ; Qureshi MB; Khan AJ; Khan MD; Ahmad K
J Ayub Med Coll Abbottabad; 2006; 18(3):40-3. PubMed ID: 17348311
[TBL] [Abstract][Full Text] [Related]
4. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
Scanlon PH; Foy C; Chen FK
Br J Ophthalmol; 2008 Jun; 92(6):775-8. PubMed ID: 18356262
[TBL] [Abstract][Full Text] [Related]
5. Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes.
Chatterjee S; Savant VV; Stavrou P
Eye (Lond); 2004 Jun; 18(6):575-9. PubMed ID: 14716320
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of diabetic retinopathy in Trang province determined by retinal photography and comprehensive eye examination.
Supapluksakul S; Ruamviboonsuk P; Chaowakul W
J Med Assoc Thai; 2008 May; 91(5):716-22. PubMed ID: 18672638
[TBL] [Abstract][Full Text] [Related]
7. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
[TBL] [Abstract][Full Text] [Related]
8. Screening for diabetic retinopathy using the mobile retinal camera: the Waikato experience.
Reda E; Dunn P; Straker C; Worsley D; Gross K; Trapski I; Whitcombe S
N Z Med J; 2003 Aug; 116(1180):U562. PubMed ID: 14581984
[TBL] [Abstract][Full Text] [Related]
9. Screening compliance and visual outcome in diabetes.
Zoega GM; Gunnarsdóttir T; Björnsdóttir S; Hreietharsson AB; Viggósson G; Stefánsson E
Acta Ophthalmol Scand; 2005 Dec; 83(6):687-90. PubMed ID: 16396645
[TBL] [Abstract][Full Text] [Related]
10. Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study.
Tapp RJ; Zimmet PZ; Harper CA; McCarty DJ; Chitson P; Tonkin AM; Söderberg S; Taylor HR; Alberti KG; Tuomilehto J; Shaw JE
Diabetes Res Clin Pract; 2006 Sep; 73(3):298-303. PubMed ID: 16584802
[TBL] [Abstract][Full Text] [Related]
11. Progression of diabetic maculopathy in patients on the Wellington Diabetic Screening Programme initially graded M3.
Avery N; Chan K; Maslin K
N Z Med J; 2013 Apr; 126(1372):32-6. PubMed ID: 23793175
[TBL] [Abstract][Full Text] [Related]
12. Comparison of optometry vs digital photography screening for diabetic retinopathy in a single district.
Tu KL; Palimar P; Sen S; Mathew P; Khaleeli A
Eye (Lond); 2004 Jan; 18(1):3-8. PubMed ID: 14707956
[TBL] [Abstract][Full Text] [Related]
13. Second eye cataract surgery in the diabetes patient? Quality of life gains and speed of visual and functional rehabilitation.
Mozaffarieh M; Heinzl H; Sacu S; Wedrich A
Ophthalmic Res; 2009; 41(1):2-8. PubMed ID: 18849635
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with regular eye examinations in people with diabetes: results from the Victorian Population Health Survey.
Müller A; Lamoureux E; Bullen C; Keeffe JE
Optom Vis Sci; 2006 Feb; 83(2):96-101. PubMed ID: 16501411
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study.
Wang FH; Liang YB; Zhang F; Wang JJ; Wei WB; Tao QS; Sun LP; Friedman DS; Wang NL; Wong TY
Ophthalmology; 2009 Mar; 116(3):461-7. PubMed ID: 19168222
[TBL] [Abstract][Full Text] [Related]
16. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center--the Joslin Vision Network Eye Health Care Model.
Cavallerano AA; Cavallerano JD; Katalinic P; Blake B; Rynne M; Conlin PR; Hock K; Tolson AM; Aiello LP; Aiello LM;
Am J Ophthalmol; 2005 Apr; 139(4):597-604. PubMed ID: 15808153
[TBL] [Abstract][Full Text] [Related]
17. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
[TBL] [Abstract][Full Text] [Related]
18. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes.
Soto-Pedre E; Hernaez-Ortega MC; Piniés JA
Ophthalmic Epidemiol; 2007; 14(2):76-9. PubMed ID: 17464854
[TBL] [Abstract][Full Text] [Related]
19. Socio-economic and ethnic inequalities in diabetes retinal screening.
Gulliford MC; Dodhia H; Chamley M; McCormick K; Mohamed M; Naithani S; Sivaprasad S
Diabet Med; 2010 Mar; 27(3):282-8. PubMed ID: 20536490
[TBL] [Abstract][Full Text] [Related]
20. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme.
Misra A; Bachmann MO; Greenwood RH; Jenkins C; Shaw A; Barakat O; Flatman M; Jones CD
Diabet Med; 2009 Oct; 26(10):1040-7. PubMed ID: 19900237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
